Linda Burkly, EVP and Chief Scientific Officer at Editas Medicine ($EDIT), made five open market sales of company shares over the past year, totaling nearly $19,000. Her most recent sale occurred on March 3, 2026. These transactions rank her 11,061st out of 11,678 insiders in our database by sale value, well below the average of $8.6 million across 6.4 transactions per seller. She reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 292856 | $0.00 | 292,856.0000 | 97,618,660 | 9999.99% | 0.30% |
| March 3, 2026 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 749 | $2.02 | 68,028.0000 | 97,618,660 | 1.09% | 0.00% |
| Dec. 3, 2025 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 713 | $2.15 | 68,777.0000 | 97,618,660 | 1.03% | 0.00% |
| Sept. 3, 2025 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 710 | $2.60 | 69,490.0000 | 82,976,284 | 1.01% | 0.00% |
| July 31, 2025 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 5121 | $2.49 | 64,398.0000 | 82,976,284 | 7.37% | 0.01% |
| June 3, 2025 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 726 | $1.72 | 69,519.0000 | 82,976,284 | 1.03% | 0.00% |
| March 8, 2025 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 82,976,284 | 9999.99% | 0.08% |
| March 8, 2025 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 275100 | $0.00 | 275,100.0000 | 82,976,284 | 9999.99% | 0.33% |
| March 4, 2025 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2891 | $1.71 | 70,245.0000 | 82,976,284 | 3.95% | 0.00% |
| July 25, 2024 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Stock | 11886 | $5.42 | 73,136.0000 | 0 | 13.98% | 0.00% |
| March 2, 2024 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 74400 | $0.00 | 74,400.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2024 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Common Stock | 15055 | $0.00 | 85,022.0000 | 0 | 21.52% | 0.00% |
| March 2, 2024 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Common Stock | 24800 | $0.00 | 69,967.0000 | 0 | 54.91% | 0.00% |
| July 24, 2023 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Common Stock | 45167 | $0.00 | 45,167.0000 | 0 | 9999.99% | 0.00% |
| July 24, 2023 | Editas Medicine, Inc. | $EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 135500 | $0.00 | 135,500.0000 | 0 | 9999.99% | 0.00% |